Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 1
1980 1
1981 5
1982 3
1983 4
1984 3
1985 4
1986 9
1987 8
1988 9
1989 4
1990 6
1991 3
1992 7
1993 8
1994 9
1995 6
1996 14
1997 12
1998 7
1999 13
2000 9
2001 17
2002 15
2003 16
2004 24
2005 28
2006 33
2007 46
2008 51
2009 47
2010 63
2011 74
2012 88
2013 106
2014 120
2015 127
2016 157
2017 160
2018 191
2019 247
2020 242
2021 296
2022 407
2023 422
2024 209

Text availability

Article attribute

Article type

Publication date

Search Results

2,960 results

Results by year

Filters applied: . Clear all
Page 1
ThermomiR-377-3p-induced suppression of Cirbp expression is required for effective elimination of cancer cells and cancer stem-like cells by hyperthermia.
Lin TY, Jia JS, Luo WR, Lin XL, Xiao SJ, Yang J, Xia JW, Zhou C, Zhou ZH, Lin SJ, Li QW, Yang ZZ, Lei Y, Yang WQ, Shen HF, Huang SH, Wang SC, Chen LB, Yang YL, Xue SW, Li YL, Dai GQ, Zhou Y, Li YC, Wei F, Rong XX, Luo XJ, Zhao BX, Huang WH, Xiao D, Sun Y. Lin TY, et al. Among authors: xue sw. J Exp Clin Cancer Res. 2024 Feb 29;43(1):62. doi: 10.1186/s13046-024-02983-3. J Exp Clin Cancer Res. 2024. PMID: 38419081 Free PMC article.
Stroke-induced damage on the blood-brain barrier.
Xue S, Zhou X, Yang ZH, Si XK, Sun X. Xue S, et al. Front Neurol. 2023 Sep 28;14:1248970. doi: 10.3389/fneur.2023.1248970. eCollection 2023. Front Neurol. 2023. PMID: 37840921 Free PMC article. Review.
First-in-human phase I/Ib study of QL1706 (PSB205), a bifunctional PD1/CTLA4 dual blocker, in patients with advanced solid tumors.
Zhao Y, Ma Y, Zang A, Cheng Y, Zhang Y, Wang X, Chen Z, Qu S, He J, Chen C, Jin C, Zhu D, Li Q, Liu X, Su W, Ba Y, Hao Y, Chen J, Zhang G, Qu S, Li Y, Feng W, Yang M, Liu B, Ouyang W, Liang J, Yu Z, Kang X, Xue S, Yang G, Yan W, Yang Y, Liu Z, Peng Y, Fanslow B, Huang X, Zhang L, Zhao H. Zhao Y, et al. Among authors: xue s. J Hematol Oncol. 2023 May 8;16(1):50. doi: 10.1186/s13045-023-01445-1. J Hematol Oncol. 2023. PMID: 37158938 Free PMC article. Clinical Trial.
2,960 results